Invoice Factoring & Trade Finance Funds: Short-Duration Yield After Greensill

TL;DR: Global factoring turnover topped €4.04 trillion in 2025, up 3.7% year over year, with US factoring volume growing more than 35%, according to the Federal Reserve's October 2025 Senior Loan Officer Opinion Survey, which shows banks tightening commercial and industrial (C&I) lending standards for small firms: shrinking credit lines, tougher collateral rules, more rate floors. That retreat is exactly the gap invoice factoring and trade finance funds are built to fill, and it's the same gap Greensill Capital tried to fill before it collapsed in March 2021, freezing roughly $10 billion in Credit Suisse-linked funds. I want to walk you through why this asset class works, why it broke once at massive scale, and what to check before you wire money into it.

The contrarian angle: banks pulling back is the opportunity, not the warning sign

Most retail investors hear "banks are tightening lending standards" and read it as a recession signal to avoid credit exposure. I read it differently. When banks shrink C&I credit lines to small and mid-sized firms, those firms still need working capital to make payroll and buy inventory while they wait 30, 60, or 90 days to get paid by their own customers. Someone has to bridge that gap. Increasingly, it's not a bank. It's a private factoring fund, structured as a Reg D offering, buying invoices at a discount and collecting the face value when the customer pays.

This isn't a new product. Factoring predates the modern bank balance sheet: Roman merchants used a version of it. What's new is the packaging. Accredited investors can now access short-duration, invoice-backed yield through pooled funds instead of only through the balance sheets of factoring companies or hedge funds. That's a legitimate structural shift. It's also exactly the setup that let Greensill Capital scale to tens of billions in assets before it evaporated in about three weeks. The opportunity and the cautionary tale come from the same root cause: banks stepping back from short-term SME credit, so you can't understand one without the other.

What the numbers actually show

Metric	Figure	Source
Global factoring turnover, 2025	€4.04 trillion, +3.7% YoY	FCI World Factoring Statistics 2025 / GTR
US factoring turnover growth, 2025	35%+ YoY	FCI World Factoring Statistics 2025 / GTR
Credit Suisse Greensill-linked funds frozen (March 2021)	~$10 billion across four funds	FINMA
Insurance cover Greensill's insurer declined to renew	$4.6 billion	FINMA
Unrecovered investor money, one year after collapse	~$2.7 billion	FINMA / swissinfo.ch
"Future receivables" in Greensill-Credit Suisse portfolios, 2018	~$470 million	UK Parliament Treasury Committee, "Lessons from Greensill Capital" (2021)
Same "future receivables" figure, 2020	$15 billion+ (~11% of total asset flow)	UK Parliament Treasury Committee (2021)
Example current Reg D receivables fund preferred return	11-12%	Kudo Business Financing Fund PPM summary

Figures on global and US factoring volume come from FCI's World Factoring Statistics 2025, as reported alongside Global Trade Review's coverage of the annual data release. The pattern in that table matters more than any single number. Greensill didn't fail because factoring is a bad idea. It failed because the share of its book made up of speculative, not-yet-issued invoices grew 30-fold in two years while a single insurer stood behind an outsized chunk of the risk. When that insurer walked away, the whole structure lost its credit support in a matter of days.

How factoring and trade finance actually work

Strip away the fund-marketing language and the mechanics are simple. A business sells goods or services to a customer and issues an invoice due in, say, 60 days. Instead of waiting 60 days to get paid, the business sells that invoice to a factor (in this case, a fund) at a discount.

• Advance rate: the percentage of the invoice's face value the fund pays upfront, typically 70% to 90% depending on the industry and customer credit quality. The business gets cash immediately instead of waiting on payment terms.
• Factoring fee: the discount the fund charges for taking on the invoice, often quoted as a percentage per 30-day period (commonly 1% to 5% per month depending on risk). This fee, annualized, is where the fund's yield comes from, and it's why well-run receivables funds can target net returns in the low-to-mid teens, in the range of the 11-12% preferred return that Kudo Business Financing Fund's PPM materials describe for a current Reg D offering.
• Recourse vs. non-recourse: in recourse factoring, if the end customer never pays, the fund can go back to the business that sold the invoice and demand repayment. In non-recourse factoring, the fund eats the loss if the customer defaults (short of fraud), so it prices that risk into the fee and underwrites the end customer's creditworthiness far more carefully. Most institutional receivables funds run primarily recourse or credit-insured books precisely because non-recourse concentration is where losses compound fastest.

The critical underwriting question is always: what, exactly, is being purchased? A real, delivered invoice with a paper trail and a creditworthy payer is a fundamentally different asset than a "future receivable": an invoice for goods or services not yet delivered, sometimes not yet even ordered. Greensill's collapse traces directly back to that second category ballooning inside its funds.

Greensill Capital: the cautionary case study, in detail

Lex Greensill built Greensill Capital into a firm that, at its peak, claimed to finance more than $140 billion in trades annually, with backing from SoftBank's Vision Fund. Credit Suisse packaged Greensill-originated receivables into four supply chain finance funds that grew to roughly $10 billion, sold largely to institutional and high-net-worth investors as safe, insurance-wrapped, short-duration credit.

Three things went wrong at once, according to the UK Parliament Treasury Committee's "Lessons from Greensill Capital" report and FINMA's 2023 findings on Credit Suisse's oversight of the funds, corroborated by contemporaneous reporting from Reuters' coverage of the fund wind-down:

• Concentration risk. A large share of the funds' exposure sat with a small number of borrowers connected to metals magnate Sanjeev Gupta's GFG Alliance and to construction startup Katerra. When those borrowers wobbled, the funds didn't have enough diversification to absorb it.
• Future receivables crept from a sliver to over a tenth of the book. The Treasury Committee found future receivables grew from about $470 million in 2018 to more than $15 billion by 2020, about 11% of total asset flow. These weren't factoring real, delivered invoices anymore. They were financing projected future sales, a materially different and harder-to-verify risk.
• Single-insurer dependency. Much of the credit protection investors were told backstopped these funds ran through a small set of policies with one Japanese insurer, Tokio Marine (via an underwriting unit it had acquired). In March 2021, that insurer declined to renew $4.6 billion in cover. Without that insurance, Credit Suisse froze the funds within days, and Greensill Capital filed for insolvency shortly after.

The aftermath: roughly $2.7 billion in investor money remained unrecovered a full year later, per FINMA's review, and the recovery process for Credit Suisse fund investors stretched past five years for meaningful portions of the book. FINMA concluded its enforcement proceedings against Credit Suisse over supervisory failures in 2023. Greensill itself never recovered. Lex Greensill's firm and its lending relationships with GFG Alliance and Katerra became the headline case study for what happens when a factoring platform outgrows its underwriting discipline.

The honest risk section

I'm not going to tell you invoice factoring funds are safe just because the underlying invoices are short-duration. Here's what can actually go wrong, in plain terms:

Concentration risk. Ask any fund sponsor directly: what percentage of the portfolio sits with the single largest obligor, and the top five? Greensill's downfall traces to concentrated exposure to a handful of related borrowers. A well-run fund should be able to give you a real number, not a vague assurance of "diversification."

Single-insurer or single-guarantor dependency. If a fund's safety pitch leans heavily on credit insurance, ask who the insurer is, what percentage of the book they cover, and what happens contractually if that insurer declines renewal, because that's precisely the scenario that froze $10 billion in Credit Suisse funds in about three weeks.

Recourse structure and what happens on default. Recourse factoring pushes non-payment risk back to the seller of the invoice. Non-recourse pushes it onto the fund. Know which one you're in, because it changes the fund's real loss exposure in a downturn far more than the headline yield tells you.

"Real" invoices versus future receivables. Ask what share of the fund's assets are financing goods and services already delivered and invoiced, versus projected future sales. Greensill's future-receivables share went from under 1% to roughly 11% of asset flow in two years without most investors noticing until it was too late.

Liquidity mismatch. Even 30-to-90-day invoices can become illiquid fast if the fund can't originate new receivables to replace maturing ones, or if redemptions outpace new invoice supply. Ask about the fund's redemption terms and what happens to your capital if originations slow.

None of this means factoring and trade finance funds are a bad allocation. It means they're a credit underwriting exercise wearing a "short-duration yield" costume, and you should evaluate them the way you'd evaluate any private credit fund: by interrogating the collateral, not the marketing deck. The International Factoring Association and FCI (Factors Chain International), the two main industry bodies that track and set standards for this market globally, both publish member codes of conduct and reporting standards. Ask a sponsor whether they belong to either body and whether they'll share portfolio-level obligor data, not just headline yield figures. A fund willing to show you real concentration numbers on request is telling you something different than one that answers with adjectives.

What to actually do next

If you're an accredited investor considering a factoring or trade finance allocation, start with the fund's private placement memorandum and go straight to three sections: obligor concentration limits, the definition of eligible receivables (real invoices only, or does it include future receivables), and the credit insurance or guarantee structure, including who the insurer is and what percentage of the book they cover. Cross-reference the sponsor's track record: how long they've originated receivables, and through what channel. For context, funds like the Kudo Business Financing Fund market that their receivables are sourced through an affiliate origination business, Direct Funding Now, with over $900 million brokered since 2015. That kind of specific, checkable origination history is a reasonable starting point for due diligence, not a substitute for it. Then talk to your own advisor about position sizing: given the concentration and insurer-dependency risks Greensill exposed, this is a slice of a diversified private credit allocation, not a core holding.

You can also track the macro backdrop yourself. The Fed's Senior Loan Officer Opinion Survey is published quarterly and free to read, and it tells you directly whether banks are still tightening C&I lending standards for small firms, which is the demand driver behind the entire factoring growth story. If banks loosen standards again, the SME liquidity gap narrows and the return-per-unit-of-risk in this space likely compresses too.

Where this leaves you

Invoice factoring and trade finance funds exist because banks have structurally reduced their appetite for short-term small-business lending, and someone has to finance the gap between when a small business delivers a product and when it gets paid. That's a real, persistent need, and funds like Kudo Business Financing Fund are pricing preferred returns around 11-12% to meet it. But Greensill Capital proved at a $10 billion scale that this model breaks when concentration, future-receivables creep, and single-insurer dependency stack on top of each other. Do the underwriting the Treasury Committee wishes Credit Suisse's own risk function had done, and you can participate in this yield without repeating 2021.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.